Q4 2024 Management View CEO Jay Mazelsky reported a solid Q4 finish, with revenue increasing 6% organically, driven by a 7% organic growth in CAG Diagnostics recurring revenue. The company achieved $2 ...
Biotech giant Bristol-Myers Squibb Company BMY is scheduled to report its fourth-quarter and full-year 2024 results on Feb. 6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback